News menu
Issues
- Access to medicines
- Antibiotic resistance
- Child health
- Cholera
- COVID-19 (Coronavirus disease)
- COVID-19 vaccines
- Ebola
- Epidemics and pandemics
- Hepatitis C
- HIV/AIDS
- Malaria
- Malnutrition
- Maternal health
- Measles
- Mental health
- Natural disasters
- Neglected diseases
- Non-communicable diseases
- Refugees
- Rohingya refugee crisis
- Sexual violence
- Surgery and trauma care
- (-) Tuberculosis (TB)
- Vaccination
- Women’s health
- War and conflict
- Health promotion
- Emergency response
- Adolescent health
- Search and Rescue
- disease
- vacc
- Infectious diseases
- violen
- Mediterranean Migration
- Climate emergency
![Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB](https://doctorswithoutborders-apac.org/sites/default/files/styles/stories_feed/public/2023-03/MSB141890_Medium.jpg?h=82f92a78&itok=kqJxqKB4)
Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB
Doctors Without Borders /Médecins Sans Frontières(MSF) called on governments and donors today to speed up access to new, shorter, safer and more effec...
Access to medicines
Tuberculosis (TB)
![Doctors Without Borders and its partners’ TB PRACTECAL Clinical Trial will be included in the updated WHO global guidance on treatment](https://doctorswithoutborders-apac.org/sites/default/files/styles/stories_feed/public/2022-05/MSB111683_Medium.jpg?h=707772c7&itok=HBw0VbzR)
Doctors Without Borders and its partners’ TB PRACTECAL Clinical Trial will be included in the updated WHO global guidance on treatment
Geneva, 3 May2022 - Doctors Without Borders / Médecins Sans Frontières (MSF) are pleased that,having shared the results of TBPRACTECAL, our clinical t...
Access to medicines
Tuberculosis (TB)
Pagination